Single-Use Bioprocessing Market Overview
The Single-Use Bioprocessing Market is expanding rapidly as biopharmaceutical manufacturers increasingly adopt disposable systems to improve manufacturing flexibility, reduce cross-contamination risks, and lower operational costs. Advances in materials, sensors, connection technologies, automation, and real-time monitoring are further strengthening the adoption of single-use solutions across biopharmaceutical production.
The market was valued at USD 8.3 billion in 2024 and is projected to grow from USD 9.2 billion in 2025 to USD 25 billion by 2035, registering a 10.6% CAGR during 2026–2035. North America leads the market, valued at USD 4 billion in 2024 and projected to reach USD 10 billion by 2035, while Asia-Pacific is expected to record the highest growth rate. Filtration is the leading application, valued at USD 1.233 billion in 2024 and projected to reach USD 3.879 billion by 2035.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/reports/single-use-bioprocessing-market
Key Players
CITEC, ABEC, Repligen Corporation, Danaher Corporation, Fujifilm Diosynth Biotechnologies, Lonza Group, Kornelis, Eppendorf AG, Western Biotech, Cellares, Pall Corporation, Thermo Fisher Scientific, Meissner Filtration Products, GE Healthcare, Merck KGaA, and Sartorius AG are among the key companies profiled in the Single-Use Bioprocessing Market.
Market Drivers and Trends
The growing demand for biologics is a major market driver. Pharmaceutical and biotechnology companies are increasingly using single-use technologies to support flexible and efficient manufacturing while avoiding the extensive cleaning and sterilization requirements associated with traditional reusable equipment.
Cost efficiency and reduced contamination risk are encouraging manufacturers to transition toward disposable bioprocessing systems. Single-use platforms can simplify facility operations and allow companies to adapt production capacity more quickly to changing demand.
Technological advancements in materials and system design are also supporting market growth. Improved connection systems, sensors, and real-time monitoring capabilities are enhancing the safety, reliability, and performance of single-use equipment.
The increasing adoption of personalized medicine, cell therapies, and gene therapies is creating additional demand for flexible manufacturing systems. Single-use technologies are particularly suited to smaller and more customized production runs, supporting their adoption by emerging biotechnology companies.
Market Segmentation
By application, the market is segmented into Cell Culture, Virus Production, Protein Purification, Filtration, and Buffer Preparation. Filtration is the largest application, valued at USD 1.233 billion in 2024 and projected to reach USD 3.879 billion by 2035. Cell Culture is also benefiting from increasing production of monoclonal antibodies and cell-based therapies.
By product type, the market includes Bioreactors, Filtration Devices, Bags and Containers, Tubing and Connectors, and Service and Support. Bioreactors and filtration devices are central to single-use manufacturing, while bags, containers, tubing, and connectors provide the disposable infrastructure required for closed and flexible processing.
By end user, the market is divided into Pharmaceutical Companies, Biotechnology Companies, CROs, and Academic Research Institutions. Pharmaceutical and biotechnology companies represent major demand centers as they increasingly adopt scalable single-use systems for biologics and advanced therapies.
By material, the market comprises Plastic, Elastomers, Silicone, and Polypropylene. Improvements in material performance are supporting greater durability, compatibility, and safety while helping manufacturers meet increasingly demanding bioprocessing requirements.
Market Opportunities
The rapidly growing biopharmaceutical industry offers substantial opportunities for single-use technology providers. Rising production of biologics, vaccines, cell therapies, and gene therapies is increasing the need for flexible manufacturing infrastructure.
Emerging biotechnology companies represent another attractive opportunity because single-use systems can allow smaller manufacturers to establish scalable production without making the same level of investment in permanent infrastructure required by traditional systems.
Digital technologies, data analytics, and digital twins provide opportunities to optimize bioprocessing operations, improve predictive maintenance, and reduce downtime. Manufacturers can also differentiate themselves through next-generation materials designed to improve performance while addressing sustainability concerns.
Recent Developments and Market Trends:
Lonza announced a strategic partnership with Meissner Filtration Products in March 2025 to co-develop next-generation single-use filtration solutions for scalable bioprocessing and closed-system manufacturing of biologics.
Cellares launched its CellsPod automated, modular cell-therapy manufacturing platform in June 2025, integrating with existing single-use bioprocess components to support scalable closed manufacturing.
Pall Corporation secured a major contract in May 2025 to supply end-to-end single-use bioprocessing systems, including filtration, purification, and containment components, for early- and late-stage production.
The industry is increasingly emphasizing larger-scale disposable bioreactors as manufacturers seek to increase production capacity while avoiding the cleaning and sterilization costs associated with traditional systems.
Sustainability and digitalization are becoming increasingly important, with manufacturers exploring environmentally improved materials, data analytics, digital twins, smart manufacturing, and real-time process monitoring to enhance efficiency and reduce waste.
Reasons to Buy the Report:
Understand the market size, 10.6% CAGR, forecast trajectory, regional outlook, application landscape, and competitive environment of the global Single-Use Bioprocessing Market.
Evaluate growth opportunities across Cell Culture, Virus Production, Protein Purification, Filtration, and Buffer Preparation and identify the applications contributing to market expansion.
Assess the competitive potential of bioreactors, filtration devices, bags and containers, tubing and connectors, and related service and support offerings.
Identify emerging opportunities associated with biologics manufacturing, personalized medicine, cell and gene therapies, automation, digital twins, and advanced single-use materials.
Gain competitive intelligence on leading companies, strategic partnerships, technological developments, regional expansion prospects, and evolving bioprocessing trends through 2035.
Future Outlook
The Single-Use Bioprocessing Market is positioned for strong expansion through 2035 as pharmaceutical and biotechnology companies continue shifting toward flexible, scalable, and cost-effective manufacturing systems. The market is projected to increase from USD 9.2 billion in 2025 to USD 25 billion by 2035 at a 10.6% CAGR.
North America is expected to maintain its leadership because of its strong biopharmaceutical research base and advanced manufacturing capabilities. Asia-Pacific is positioned as the fastest-growing regional market, supported by expanding healthcare infrastructure and increasing investment in biopharmaceutical production.
Future development is likely to focus on advanced materials, automated and connected systems, real-time monitoring, digital twins, sustainable manufacturing, and single-use platforms designed for personalized medicine and advanced therapies. These developments should further strengthen the role of disposable technologies across the global bioprocessing industry.
